SEARCH RESULTS FOR: 得克萨斯A(13611 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0066
In Commercial Distribution
- 07540127000505 ()
- 07540127000499 ()
- 07540127000512 ()
- Area/Surface Area: 512 Square inch
CL1632
- Wound-nonadherent dressing, absorbent, antimicrobial
antimicrobial wound dressing, 4" x 66" in size
Exciton Technologies Inc
BM-09-0166
In Commercial Distribution
- 07540127000468 ()
- 07540127000475 ()
- 07540127000482 ()
T70466
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0065
In Commercial Distribution
- 07540127000444 ()
- 07540127000437 ()
- 07540127000451 ()
- Area/Surface Area: 256 Square inch
CL1616
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0064
In Commercial Distribution
- 07540127000413 ()
- 07540127000406 ()
- 07540127000420 ()
- Area/Surface Area: 128 Square inch
CL0816
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0063
In Commercial Distribution
- 07540127000383 ()
- 07540127000376 ()
- 07540127000390 ()
- Area/Surface Area: 36 Square inch
CL0606
- Wound-nonadherent dressing, absorbent, antimicrobial
The exsalt™ PT7 Contact Layer (PT7) is indicated for use on partial and full thickness wounds, including decubitus ulcers, venous stasis ulcers, diabetic ulcers, first and second-degree burns, grafts and donor sites, or other acute or chronic wounds. The dressing may be used over debrided and graft wounds. The exsalt™ PT7 Contact Layer maintains its antibacterial activity for up to seven days as shown in vitro against Staphylococcus aureus, Escherichia coli, Enterococcus faecalis, Staphylococcus epidermidis, Pseudomonas aeruginosa, and Acinetobacter baumannii. Silver in the exsalt™ PT7 Contact Layer inhibits bacterial growth in the dressing.
Exciton Technologies Inc
PN-09-0062
In Commercial Distribution
- 07540127000352 ()
- 07540127000345 ()
- 07540127000369 ()
- Area/Surface Area: 20 Square inch
CL0405
- Wound-nonadherent dressing, absorbent, antimicrobial
antimicrobial wound dressing, sterile, 40cm x 80cm
Exciton Technologies Inc
09-0132
In Commercial Distribution
- 07540127000147 ()
- 07540127000130 ()
- 07540127000154 ()
- Area/Surface Area: 3200 Square centimeter
T71632
- Wound-nonadherent dressing, absorbent, antimicrobial
antimicrobial wound dressing, sterile, size 40cm x 40cm
Exciton Technologies Inc
09-0116
In Commercial Distribution
- 07540127000116 ()
- 07540127000109 ()
- 07540127000123 ()
- Area/Surface Area: 1600 Square centimeter
T71616
- Wound-nonadherent dressing, absorbent, antimicrobial
antimicrobial wound dressing, size 20cm x 40cm
Exciton Technologies Inc
09-0108
In Commercial Distribution
- 07540127000086 ()
- 07540127000079 ()
- 07540127000093 ()
- Area/Surface Area: 800 Square centimeter
T70816
- Wound-nonadherent dressing, absorbent, antimicrobial
antimicrobial wound dressing, size 15cm x 15cm
Exciton Technologies Inc
09-0105
In Commercial Distribution
- 07540127000055 ()
- 07540127000048 ()
- 07540127000062 ()
- Area/Surface Area: 125 Square centimeter
T70606
- Wound-nonadherent dressing, absorbent, antimicrobial